MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI, stock code: 688114.SH) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries. Founded in 2016 and listed in 2022, MGI has grown into a leader in life science, serving customers across six continents and has established research, manufacturing, training, and after-sales service facilities globally. As one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers, MGI empowers global users with scalable sequencing capabilities ranging from Gb to Tb levels. MGI also stands out as the only provider of a full-stack product portfolio that spans three core segments: SEQ ALL (short-and long-read sequencing), GLI (Generative Lab Intelligence), and Multi-Omics.
| Website | https://en.mgi-tech.com/ |
| Revenue | $73.7 million |
| Employees | 1,428 (298 on RocketReach) |
| Founded | 2016 |
| Industry | Biotechnology Research |
| Competitors | Illumina, Thermo Fisher Scientific, PacBio, Bio-Rad Laboratories, Bristol Myers Squibb, Agilent Technologies, 10x Genomics, Oxford Nanopore Technologies, Roche, QIAGEN +39 more (view full list) |
Looking for a particular MGI employee's phone or email?
The MGI annual revenue was $73.7 million in 2026.
Christian Zimmermann is the VP of Sales Europe and Africa of MGI.
298 people are employed at MGI.